Paper33489124
Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease.
Denny L and 6 others. Clin Transl Immunology, 2021. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease. Papers, record 33489124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33489124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 DA018151 | NIDA NIH HHS | United States | R01DA018151 | PubMed |
Source NIH RePORTER
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29873694 | The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. | Brain | 2018 | https://conductscience.org/library/papers/29873694 | PubMed |
| 2 | 26483787 | Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. | Front Immunol | 2015 | https://conductscience.org/library/papers/26483787 | PubMed |
| 3 | 32023490 | Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells that Promote Pathogenic T Cells. | Immunity | 2020 | https://conductscience.org/library/papers/32023490 | PubMed |
| 4 | 25946987 | Multiple Sclerosis and T Lymphocytes: An Entangled Story. | J Neuroimmune Pharmacol | 2015 | https://conductscience.org/library/papers/25946987 | PubMed |
| 5 | 14734610 | IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. | Int Immunol | 2004 | https://conductscience.org/library/papers/14734610 | PubMed |
| 6 | 23794649 | Opioids and immune modulation: more questions than answers. | Br J Anaesth | 2013 | https://conductscience.org/library/papers/23794649 | PubMed |
| 7 | 31492823 | Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine. | J Pharmacol Exp Ther | 2019 | https://conductscience.org/library/papers/31492823 | PubMed |
| 8 | 29915074 | Changes in white matter in mice resulting from low-frequency brain stimulation. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/29915074 | PubMed |
| 9 | 22642416 | Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity. | BMC Pharmacol | 2012 | https://conductscience.org/library/papers/22642416 | PubMed |
| 10 | 10336124 | Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study. | Neuroscience | 1999 | https://conductscience.org/library/papers/10336124 | PubMed |
| 11 | 31190170 | Promoting remyelination in multiple sclerosis. | J Neurol | 2021 | https://conductscience.org/library/papers/31190170 | PubMed |
| 12 | 26239536 | Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. | Ann Neurol | 2015 | https://conductscience.org/library/papers/26239536 | PubMed |
| 13 | 16168933 | Symptomatic therapy and neurorehabilitation in multiple sclerosis. | Lancet Neurol | 2005 | https://conductscience.org/library/papers/16168933 | PubMed |
| 14 | 23849779 | Using EAE to better understand principles of immune function and autoimmune pathology. | J Autoimmun | 2013 | https://conductscience.org/library/papers/23849779 | PubMed |
| 15 | 20372880 | Kappa opioids and the modulation of pain. | Psychopharmacology (Berl) | 2010 | https://conductscience.org/library/papers/20372880 | PubMed |
| 16 | 1326932 | Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. | Arch Int Pharmacodyn Ther | 1992 | https://conductscience.org/library/papers/1326932 | PubMed |
| 17 | 18397264 | T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis. | Immunology | 2008 | https://conductscience.org/library/papers/18397264 | PubMed |
| 18 | 11390514 | Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. | J Immunol | 2001 | https://conductscience.org/library/papers/11390514 | PubMed |
| 19 | 27466337 | Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination. | J Neurosci | 2016 | https://conductscience.org/library/papers/27466337 | PubMed |
| 20 | 26985446 | Opioid System Modulates the Immune Function: A Review. | Transl Perioper Pain Med | 2016 | https://conductscience.org/library/papers/26985446 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942096 | Effects of Zinc Deficiency and Supplementation on Hippocampal ZnT3, NOGO-A, IL-6, and SESN2 Expression and Oxidative Stress Markers in a Cuprizone-Induced Toxic Demyelination Model. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42942096 | PubMed |
| 42123700 | Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123700 | PubMed |
| 41573725 | κ-opioid receptor: from analgesic target to neuroimmune hub. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41573725 | PubMed |
| 41395357 | Nalmefene enhances the remyelinating ability of nalfurafine when administered therapeutically at very low doses during experimental autoimmune encephalomyelitis. | Clin Transl Immunology | 2025 | https://conductscience.org/library/papers/41395357 | PubMed |
| 38960136 | Limitations and potential of κOR biased agonists for pain and itch management. | Neuropharmacology | 2024 | https://conductscience.org/library/papers/38960136 | PubMed |
| 38090669 | Enhanced and complementary benefits of a nalfurafine and fingolimod combination to treat immune-driven demyelination. | Clin Transl Immunology | 2023 | https://conductscience.org/library/papers/38090669 | PubMed |
| 36906681 | Molecular mechanism of biased signaling at the kappa opioid receptor. | Nat Commun | 2023 | https://conductscience.org/library/papers/36906681 | PubMed |
| 36555733 | Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36555733 | PubMed |
| 36408401 | Signaling underlying kappa opioid receptor-mediated behaviors in rodents. | Front Neurosci | 2022 | https://conductscience.org/library/papers/36408401 | PubMed |
| 35795569 | The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35795569 | PubMed |
| 35101565 | An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects. | Pharmacol Res | 2022 | https://conductscience.org/library/papers/35101565 | PubMed |
| 35001353 | Paeonol Ameliorates Cuprizone-Induced Hippocampal Demyelination and Cognitive Deficits through Inhibition of Oxidative and Inflammatory Events. | J Mol Neurosci | 2022 | https://conductscience.org/library/papers/35001353 | PubMed |
| 34987466 | The Salvinorin Analogue, Ethoxymethyl Ether Salvinorin B, Promotes Remyelination in Preclinical Models of Multiple Sclerosis. | Front Neurol | 2021 | https://conductscience.org/library/papers/34987466 | PubMed |
| 34799634 | Cuprizone feed formulation influences the extent of demyelinating disease pathology. | Sci Rep | 2021 | https://conductscience.org/library/papers/34799634 | PubMed |
| 34602975 | Multiple Sclerosis and the Endogenous Opioid System. | Front Neurosci | 2021 | https://conductscience.org/library/papers/34602975 | PubMed |
| 34596819 | Intranasal Salvinorin A Improves Long-term Neurological Function via Immunomodulation in a Mouse Ischemic Stroke Model. | J Neuroimmune Pharmacol | 2022 | https://conductscience.org/library/papers/34596819 | PubMed |
| 34308635 | Plant-Derived Cyclotides Modulate κ-Opioid Receptor Signaling. | J Nat Prod | 2021 | https://conductscience.org/library/papers/34308635 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| FOXP3 | 50943 | PubTator's text mining | https://conductscience.org/library/genes/50943 | NCBI Gene |
| IL2RA | 3559 | PubTator's text mining | https://conductscience.org/library/genes/3559 | NCBI Gene |
| ITGAM | 3684 | PubTator's text mining | https://conductscience.org/library/genes/3684 | NCBI Gene |
| MAPK14 | 1432 | PubTator's text mining | https://conductscience.org/library/genes/1432 | NCBI Gene |
| OPRK1 | 4986 | PubTator's text mining | https://conductscience.org/library/genes/4986 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33489124
GET https://conductscience.org/api/papers/v1/33489124/references?page=2